The synthetic antineoplastic drug cladribine is mainly used to treat specific forms of lymphoma and leukemia. It comes from a class of medications called purine analogs, which disrupt DNA synthesis and repair, eventually causing fast-dividing cells, like cancer cells, to die. Cladribine market is predicted to develop at a compound annual growth rate (CAGR) of xx% from 2024 to 2034, when it is projected to reach USD xx Million, based on an average growth pattern
This drug is either orally or intravenously, and it is usually used in cycles to give the body time to recuperate between dosages. Cladribine functions by producing damage to cancer cells' DNA, which stops them from multiplying and ultimately leads to their extinction. Its ability to identify only malignant cells reduces harm to healthy organs.
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation